SCHEMBL5157140

SCHEMBL5157140

CC=C(Nc1ccccc1)Nc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R38 P59533 3/20 0.52
HSD17B10 Q99714 3/20 0.52
NAPRT Q6XQN6 1/20 0.52
ALDH1A1 P00352 3/20 0.50
TSHR P16473 3/20 0.50
TP53 P04637 2/20 0.50
EPHX1 P07099 1/20 0.50
EPHX2 P34913 1/20 0.50
CDK9 P50750 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CLK4 Q9HAZ1 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP1A2 P05177 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
KMT2A Q03164 4/20 0.47
GAA P10253 3/20 0.47
MAPT P10636 3/20 0.47
MEN1 O00255 3/20 0.47
LMNA P02545 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18676955 0.79 TAS2R38 (0.52) TAS2R38HSD17B10NAPRTALDH1A1TSHR
SCHEMBL12440049 0.77 MAPT (0.61) TAS2R38HSD17B10NAPRTALDH1A1TSHR
SCHEMBL11518052 0.77 TDP1 (0.54) SMN1; SMN2CYP3A4CYP1A2KMT2AMAPT
SCHEMBL12113186 0.77 MAPT (0.61) TAS2R38HSD17B10NAPRTALDH1A1TSHR
SCHEMBL9253909 0.77 MAPT (0.61) TAS2R38HSD17B10NAPRTALDH1A1TSHR
SCHEMBL3110483 0.75 ALDH1A1 (0.54) TAS2R38HSD17B10NAPRTALDH1A1TSHR
SCHEMBL1185133 0.73 TGM2 (0.63) HSD17B10NAPRTTSHRTP53EPHX1
SCHEMBL14347590 0.72 TAS2R38 (0.64) TAS2R38HSD17B10NAPRTALDH1A1TSHR
SCHEMBL13381399 0.72 TAS2R38 (0.64) TAS2R38HSD17B10NAPRTALDH1A1TSHR
SCHEMBL1455001 0.72 TAS2R38 (0.64) TAS2R38HSD17B10NAPRTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637439-B2 Preparation of cannabichromene and related cannabinoids BAYMEDICA, INC. (US) 2026-05-26 US claimed
US-20230063862-A1 PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS BAYMEDICA, INC. 2023-03-02 US claimed
WO-2004018569-A1 METHOD FOR PRODUCING ADDITIVE CARBON BLACK COLUMBIAN CHEMICALS COMPANY (US) 2004-03-04 WO claimed
US-20020165302-A1 Mixing an amine antidegradant with carbon black, free of a solvent or carrier; improving dispersion, viscosity when mixing with rubber, time reduction, cost savings and reduces environmental impact COLUMBIAN CHEMICALS COMPANY 2002-11-07 US claimed
US-4764547-A WITH AMINE OR QUINOLINE COMPOUND BRIDGESTONE CORPORATION (JP) 1988-08-16 US claimed
EP-0042725-B1 PROCESS FOR SUSPENSION-POLYMERIZING VINYL CHLORIDE TOKUYAMA SEKISUI KOGYO KABUSHIKI KAISHA (JP) 1984-09-19 EP claimed
US-4404337-A Process for inhibiting the formation of scale in the suspension polymerization of vinyl chloride TOKUYAMA SEKISUI KOGYO KABUSHIKI KAISHA (JP) 1983-09-13 US claimed
EP-0042725-A1 Process for suspension-polymerizing vinyl chloride TOKUYAMA SEKISUI KOGYO KABUSHIKI KAISHA (JP) 1981-12-30 EP claimed
US-12637439-B2 Preparation of cannabichromene and related cannabinoids BAYMEDICA, INC. (US) 2026-05-26 US disclosed
US-12466907-B2 Acrylic rubber composition and rubber crosslinked product ZEON CORPORATION (JP) 2025-11-11 US disclosed
EP-4130131-B1 ACRYLIC RUBBER COMPOSITION AND RUBBER CROSSLINKED PRODUCT ZEON CORP (JP) 2025-07-09 EP disclosed
US-20230167270-A1 ACRYLIC RUBBER COMPOSITION AND RUBBER CROSSLINKED PRODUCT ZEON CORPORATION (JP) 2023-06-01 US disclosed
US-20230063862-A1 PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS BAYMEDICA, INC. 2023-03-02 US disclosed
EP-4130131-A1 ACRYLIC RUBBER COMPOSITION AND RUBBER CROSSLINKED PRODUCT Zeon Corporation (JP) 2023-02-08 EP disclosed
US-5344861-A Polymer blend with organic acid, phenylamine, phenylenediamine and acid acceptor with vulcanization agent TOSOH CORPORATION (JP) 1994-09-06 US disclosed
EP-0413305-A1 Chlorosulfonated polyethylene polymer composition TOSOH CORPORATION (JP) 1991-02-20 EP disclosed
US-4764547-A WITH AMINE OR QUINOLINE COMPOUND BRIDGESTONE CORPORATION (JP) 1988-08-16 US disclosed
US-4404337-A Process for inhibiting the formation of scale in the suspension polymerization of vinyl chloride TOKUYAMA SEKISUI KOGYO KABUSHIKI KAISHA (JP) 1983-09-13 US disclosed
US-4179469-A Preparation of amines UOP INC. (US) 1979-12-18 US disclosed
US-4013618-A NITROGEN-CONTAINING STABILIZER TOYOBO CO., LTD. (JA) 1977-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637439-B2 Preparation of cannabichromene and related cannabinoids CNR2, CNR1, OPRM1 TAS2R38 1340/4885HSD17B10 648/4885NAPRT 2240/4885
US-20230063862-A1 PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS CNR2, CNR1, SQLE TAS2R38 1650/4885HSD17B10 2268/4885NAPRT 1712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.